title: Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.
authors.affiliation: Duke University Medical Center, Durham, North Carolina, USA. megan.clowse@duke.edu
authors.forename: Megan E B
authors.initials: ME
authors.lastname: Clowse
authors.forename: Lindsey
authors.initials: L
authors.lastname: Harward
authors.forename: Lisa
authors.initials: L
authors.lastname: Criscione-Schreiber
authors.forename: David
authors.initials: D
authors.lastname: Pisetsky
authors.forename: Susannah
authors.initials: S
authors.lastname: Copland
mesh_terms: D000367:Age Factors; D054304:Anti-Mullerian Hormone / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D003520:Cyclophosphamide / Q000633:toxicity*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000633:toxicity*; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000175:diagnosis / Q000378:metabolism; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D015415:Biomarkers; D007166:Immunosuppressive Agents; D054304:Anti-Mullerian Hormone; D003520:Cyclophosphamide; D005640:Follicle Stimulating Hormone